The Role of HIV in Serious Diseases Other Than AIDS

Overview

Journal AIDS

Specialty Infectious Diseases

Date 2008 Nov 14

PMID 19005264

Citations 126

Authors

Andrew N Phillips

James Neaton

Jens D Lundgren

Affiliations

Soon will be listed here.

Citing Articles

HIV-SEQ REVEALS GLOBAL HOST GENE EXPRESSION DIFFERENCES BETWEEN HIV-TRANSCRIBING CELLS FROM VIREMIC AND SUPPRESSED PEOPLE WITH HIV.

Frouard J, Telwatte S, Luo X, Elphick N, Thomas R, Arneson D bioRxiv. 2025; .

PMID: 39763963 PMC: 11702770. DOI: 10.1101/2024.12.17.629023.

Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2.

Opsteen S, Fram T, Files J, Levitan E, Goepfert P, Erdmann N J Acquir Immune Defic Syndr. 2024; 96(1):92-100.

PMID: 38408318 PMC: 11009054. DOI: 10.1097/QAI.0000000000003399.

Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV.

Reilly C, Borges A, Baker J, Safo S, Sharma S, Polizzotto M J Infect Dis. 2022; 227(8):951-960.

PMID: 36580481 PMC: 10319949. DOI: 10.1093/infdis/jiac496.

New Assay Reveals Vast Excess of Defective over Intact HIV-1 Transcripts in Antiretroviral Therapy-Suppressed Individuals.

Martin H, Kadiyala G, Telwatte S, Wedrychowski A, Chen T, Moron-Lopez S J Virol. 2022; 96(24):e0160522.

PMID: 36448806 PMC: 9769383. DOI: 10.1128/jvi.01605-22.

Human immunodeficiency virus infection and risks of morbidity and death in adults with incident heart failure.

Avula H, Ambrosy A, Silverberg M, Reynolds K, Towner W, Hechter R Eur Heart J Open. 2022; 1(3):oeab040.

PMID: 35919879 PMC: 9242035. DOI: 10.1093/ehjopen/oeab040.

References

Lucas G, Eustace J, Sozio S, Mentari E, Appiah K, Moore R . Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS. 2004; 18(3):541-6. DOI: 10.1097/00002030-200402200-00022. View

Szczech L, Gange S, van der Horst C, Bartlett J, Young M, Cohen M . Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002; 61(1):195-202. DOI: 10.1046/j.1523-1755.2002.00094.x. View

Emery S, Neuhaus J, Phillips A, Babiker A, Cohen C, Gatell J . Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008; 197(8):1133-44. DOI: 10.1086/586713. View

Bannister W, Kirk O, Gatell J, Knysz B, Viard J, Mens H . Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe. J Acquir Immune Defic Syndr. 2006; 42(2):229-37. DOI: 10.1097/01.qai.0000214815.95786.31. View

Phillips A, Gazzard B, Clumeck N, Losso M, Lundgren J . When should antiretroviral therapy for HIV be started?. BMJ. 2007; 334(7584):76-8. PMC: 1767243. DOI: 10.1136/bmj.39064.406389.94. View

Vajdic C, McDonald S, McCredie M, van Leeuwen M, Stewart J, Law M . Cancer incidence before and after kidney transplantation. JAMA. 2006; 296(23):2823-31. DOI: 10.1001/jama.296.23.2823. View

Currier J, Taylor A, Boyd F, Dezii C, Kawabata H, Burtcel B . Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr. 2003; 33(4):506-12. DOI: 10.1097/00126334-200308010-00012. View

Lau B, Sharrett A, Kingsley L, Post W, Palella F, Visscher B . C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med. 2006; 166(1):64-70. DOI: 10.1001/archinte.166.1.64. View

Kimmel P, Barisoni L, Kopp J . Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med. 2003; 139(3):214-26. View

10.

Wang T, Gona P, Larson M, Tofler G, Levy D, Newton-Cheh C . Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006; 355(25):2631-9. DOI: 10.1056/NEJMoa055373. View

11.

Smit C, Geskus R, Walker S, Sabin C, Coutinho R, Porter K . Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS. 2006; 20(5):741-9. DOI: 10.1097/01.aids.0000216375.99560.a2. View

12.

Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View

13.

Kirk G, Merlo C, O Driscoll P, Mehta S, Galai N, Vlahov D . HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis. 2007; 45(1):103-10. PMC: 4078722. DOI: 10.1086/518606. View

14.

Bruggeman L, Dikman S, Meng C, Quaggin S, Coffman T, Klotman P . Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest. 1997; 100(1):84-92. PMC: 508168. DOI: 10.1172/JCI119525. View

15.

Grabar S, Lanoy E, Allavena C, Mary-Krause M, Bentata M, Fischer P . Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy. HIV Med. 2008; 9(4):246-56. DOI: 10.1111/j.1468-1293.2008.00554.x. View

16.

Darby S, Ewart D, Giangrande P, Spooner R, Rizza C, Dusheiko G . Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet. 1997; 350(9089):1425-31. DOI: 10.1016/s0140-6736(97)05413-5. View

17.

Yamamoto T, Noble N, Miller D, Gold L, Hishida A, Nagase M . Increased levels of transforming growth factor-beta in HIV-associated nephropathy. Kidney Int. 1999; 55(2):579-92. DOI: 10.1046/j.1523-1755.1999.00296.x. View

18.

Douek D, Betts M, Hill B, Little S, Lempicki R, Metcalf J . Evidence for increased T cell turnover and decreased thymic output in HIV infection. J Immunol. 2001; 167(11):6663-8. DOI: 10.4049/jimmunol.167.11.6663. View

19.

Doublier S, Zennaro C, Spatola T, Lupia E, Bottelli A, Deregibus M . HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy. AIDS. 2007; 21(4):423-32. DOI: 10.1097/QAD.0b013e328012c522. View

20.

Szczech L, Gupta S, Habash R, Guasch A, Kalayjian R, Appel R . The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004; 66(3):1145-52. DOI: 10.1111/j.1523-1755.2004.00865.x. View